Context People affected by serious illness usually experience suffering in its various
dimensions, not only in the physical but also in the psychosocial and spiritual aspects. The …

Background: Growing clinical interest in psychedelic-assisted therapies has led to a second
wave of research involving psilocybin, lysergic acid diethylamide (LSD), 3, 4 …

Objective To investigate patterns of care during the last months of life of hospitalised patients
who died from different haematological malignancies. Methods Nationwide register-based …

Background Depression is common in patients with cancer and is associated with lower
treatment adherence and reduced quality of life. Antidepressants and psychotherapy have …

Despite resurgent interest in psychedelic-assisted therapy, our insights into psychiatrists'
knowledge and opinions about medicinal psychedelic applications are surprisingly narrow …

Background The present study explored the acceptability of psilocybin‐assisted group
therapy from the perspective of patients with cancer and depression who participated in a …

Background: Recent and preprohibition studies show that patients with serious illness might
benefit from psychedelic-assisted therapies for a range of symptoms, physical, psychosocial …

With medical advancements promoting increased longevity, the number of older adults in
the population is rapidly growing. Correspondingly, the prevalence of older adults affected …

Psychedelic-assisted therapy (PAT) is a burgeoning treatment with growing interest across a
variety of settings and disciplines. Empirical evidence supports PAT as a novel therapeutic …

Background: With support from the Radcliffe Institute for Advanced Study at Harvard
University, we convened researchers representing palliative care, psychosocial oncology …